Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps

NCT06556264 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps
Asthma

Interventions

DRUG: Dupilumab
OTHER: Placebo

Sponsor

Dr. Andrew Thamboo, MD

Collaborators

[object Object]